Cargando…

The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection

Interleukin (IL)-21 supports induction and expansion of CD8(+) T cells, and can also regulate the differentiation of B cells into antibody-producing plasma cells. We questioned whether the number of circulating donor-specific IL-21 producing cells (pc) can predict kidney transplant rejection, and ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Besouw, Nicole M., Yan, Lin, de Kuiper, Ronella, Klepper, Mariska, Reijerkerk, Derek, Dieterich, Marjolein, Roelen, Dave L., Claas, Frans H. J., Clahsen-van Groningen, Marian C., Hesselink, Dennis A., Baan, Carla C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465545/ https://www.ncbi.nlm.nih.gov/pubmed/31024571 http://dx.doi.org/10.3389/fimmu.2019.00748

Ejemplares similares

Pre-transplant donor-reactive IL-21 producing T cells as a tool to identify an increased risk for acute rejection
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2021)

Natural Antibodies and Alloreactive T Cells Long after Kidney Transplantation
por: van Besouw, Nicole M., et al.
Publicado: (2021)

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023)

Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients
por: Niu, Qian, et al.
Publicado: (2020)

High Tacrolimus Intrapatient Variability and Subtherapeutic Immunosuppression are Associated With Adverse Kidney Transplant Outcomes
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2022)

Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2018)

T-Cell Composition of the Lymph Node Is Associated with the Risk for Early Rejection after Renal Transplantation
por: Dedeoglu, Burç, et al.
Publicado: (2017)

Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study
por: Verhoeven, Jeroen G. H. P., et al.
Publicado: (2021)

Characterization of donor and recipient CD8+ tissue-resident memory T cells in transplant nephrectomies
por: de Leur, Kitty, et al.
Publicado: (2019)

Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant Rejection
por: Hullegie‐Peelen, Daphne M., et al.
Publicado: (2022)

Mast Cells in Kidney Transplant Biopsies With Borderline T Cell-mediated Rejection and Their Relation to Chronicity
por: Varol, Hilal, et al.
Publicado: (2023)

Polyfunctional donor-reactive T cells are associated with acute T-cell-mediated rejection of the kidney transplant
por: Litjens, Nicolle H R, et al.
Publicado: (2023)

The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection
por: Sablik, Kasia A., et al.
Publicado: (2020)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation
por: Dedeoglu, Burç, et al.
Publicado: (2016)

Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile
por: Wu, Yongkang, et al.
Publicado: (2017)

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection
por: van Vugt, Lukas K., et al.
Publicado: (2023)

Oxalate deposition in renal allograft biopsies within 3 months after transplantation is associated with allograft dysfunction
por: Snijders, Malou L. H., et al.
Publicado: (2019)

Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2019)

CD16+ Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection
por: van den Bosch, Thierry P. P., et al.
Publicado: (2017)

A Decentralized Kidney Transplant Biopsy Classifier for Transplant Rejection Developed Using Genes of the Banff-Human Organ Transplant Panel
por: van Baardwijk, Myrthe, et al.
Publicado: (2022)

Cholesterol Embolization Syndrome After Kidney Transplantation: A Case Series and Systematic Review
por: Francke, Marith I., et al.
Publicado: (2021)

Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation
por: de Graav, Gretchen N., et al.
Publicado: (2017)

Immune Subsets From Ficoll Density Gradient Separation in Kidney Transplant Recipients
por: Udomkarnjananun, Suwasin, et al.
Publicado: (2022)

Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness
por: Bouvy, Anne P., et al.
Publicado: (2016)

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
por: Hurkmans, Daan P., et al.
Publicado: (2019)

Diagnostic Potential of Minimally Invasive Biomarkers: A Biopsy-centered Viewpoint From the Banff Minimally Invasive Diagnostics Working Group
por: Huang, Edmund, et al.
Publicado: (2022)

Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies
por: Varol, Hilal, et al.
Publicado: (2022)

The FCGR3A 158 V/V-genotype is associated with decreased survival of renal allografts with chronic active antibody-mediated rejection
por: Litjens, Nicolle, et al.
Publicado: (2021)

Down-Regulation of Surface CD28 under Belatacept Treatment: An Escape Mechanism for Antigen-Reactive T-Cells
por: de Graav, Gretchen N., et al.
Publicado: (2016)

Boosting the VZV-Specific Memory B and T Cell Response to Prevent Herpes Zoster After Kidney Transplantation
por: Kho, Marcia M. L., et al.
Publicado: (2022)

Differential T Cell Signaling Pathway Activation by Tacrolimus and Belatacept after Kidney Transplantation: Post Hoc Analysis of a Randomised-Controlled Trial
por: Kannegieter, Nynke M., et al.
Publicado: (2017)

Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients
por: Kannegieter, Nynke M., et al.
Publicado: (2018)

The Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ Transplantation
por: Wu, Yongkang, et al.
Publicado: (2016)

The role of follicular T helper cells in the humoral alloimmune response after clinical organ transplantation
por: van Besouw, Nicole M., et al.
Publicado: (2019)

Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
por: de Weerd, Annelies, et al.
Publicado: (2014)

The Effect of Tacrolimus and Mycophenolic Acid on CD14+ Monocyte Activation and Function
por: Kannegieter, Nynke M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0vbi6c0d6v8dvj97qf8uqpfqoc